全文获取类型
收费全文 | 1340篇 |
免费 | 104篇 |
国内免费 | 5篇 |
专业分类
耳鼻咽喉 | 17篇 |
儿科学 | 68篇 |
妇产科学 | 36篇 |
基础医学 | 147篇 |
口腔科学 | 14篇 |
临床医学 | 199篇 |
内科学 | 246篇 |
皮肤病学 | 64篇 |
神经病学 | 120篇 |
特种医学 | 35篇 |
外科学 | 130篇 |
综合类 | 6篇 |
一般理论 | 2篇 |
预防医学 | 133篇 |
眼科学 | 22篇 |
药学 | 66篇 |
肿瘤学 | 144篇 |
出版年
2023年 | 12篇 |
2022年 | 7篇 |
2021年 | 30篇 |
2020年 | 27篇 |
2019年 | 47篇 |
2018年 | 50篇 |
2017年 | 35篇 |
2016年 | 42篇 |
2015年 | 51篇 |
2014年 | 50篇 |
2013年 | 71篇 |
2012年 | 98篇 |
2011年 | 98篇 |
2010年 | 58篇 |
2009年 | 56篇 |
2008年 | 79篇 |
2007年 | 97篇 |
2006年 | 85篇 |
2005年 | 68篇 |
2004年 | 76篇 |
2003年 | 81篇 |
2002年 | 66篇 |
2001年 | 11篇 |
2000年 | 11篇 |
1999年 | 10篇 |
1998年 | 10篇 |
1997年 | 14篇 |
1996年 | 7篇 |
1993年 | 7篇 |
1992年 | 5篇 |
1991年 | 8篇 |
1990年 | 6篇 |
1988年 | 3篇 |
1987年 | 7篇 |
1986年 | 5篇 |
1985年 | 3篇 |
1983年 | 3篇 |
1982年 | 6篇 |
1981年 | 2篇 |
1980年 | 2篇 |
1978年 | 2篇 |
1976年 | 4篇 |
1975年 | 6篇 |
1972年 | 2篇 |
1965年 | 2篇 |
1964年 | 3篇 |
1940年 | 2篇 |
1938年 | 2篇 |
1931年 | 2篇 |
1911年 | 2篇 |
排序方式: 共有1449条查询结果,搜索用时 218 毫秒
1.
Antoinette Falconi‐McCahill 《Journal of Midwifery & Women's Health》2019,64(5):578-591
Bacterial vaginosis is a prevalent vaginal infection that affects women of all ages. Presenting symptoms include a vaginal discharge that is thin and white and has a fishy odor. This infection is associated with the acquisition of other sexually transmitted infections as well as premature labor and preterm birth. Recurrence rates after treatment are high, and medication adverse effects are common, leading many women to seek alternative therapies to manage and prevent recurrence. Many of these treatments are searchable online, and ingredients are easily obtainable. The purpose of this article is to review the state of the science regarding the safety and efficacy of alternative therapies for the treatment of bacterial vaginosis in nonpregnant women. 相似文献
2.
Bipul Gnyawali Antoinette Pusateri Ashley Nickerson Sajid Jalil Khalid Mumtaz 《World journal of gastroenterology : WJG》2022,28(29):3793-3802
Chronic Hepatitis B is a highly prevalent disease worldwide and is estimated to cause more than 800000 annual deaths from complications such as cirrhosis and hepatocellular carcinoma (HCC). Although universal hepatitis B vaccination programs may have reduced the incidence and prevalence of chronic hepatitis B and related HCC, the disease still imposes a significant healthcare burden in many endemic regions such as Africa and the Asia-Pacific region. This is especially concerning given the global underdiagnosis of hepatitis B and the limited availability of vaccination, screening, and treatment in low-resource regions. Demographics including male gender, older age, ethnicity, and geo graphic location as well as low socioeconomic status are more heavily impacted by chronic hepatitis B and related HCC. Methods to mitigate this impact include increasing screening in high-risk groups according to national guidelines, increasing awareness and health literacy in vulnerable populations, and developing more robust vaccination programs in under-served regions. 相似文献
3.
4.
5.
Anthony W. Tolcher Razelle Kurzrock Vincente Valero Rene Gonzalez Rebecca S. Heist Antoinette R. Tan Julie Means-Powell Theresa L. Werner Carlos Becerra Chenxi Wang Cathrine Leonowens Shanker Kalyana-Sundaram Joseph F. Kleha Jennifer Gauvin Anthony M. DAmelio Catherine Ellis Nageatte Ibrahim Li Yan 《Cancer chemotherapy and pharmacology》2020,85(4):673-683
This study aimed to determine the safety, tolerability, and recommended phase II doses of trametinib plus uprosertib (GSK2141795) in patients with solid tumors likely to be sensitive to MEK and/or AKT inhibition. This was a phase I, open-label, dose-escalation, and dose-expansion study in patients with triple-negative breast cancer or BRAF-wild type advanced melanoma. The primary outcome of the expansion study was investigator-assessed response. Among 126 enrolled patients, 63 received continuous oral daily dosing of trametinib and uprosertib, 29 received various alternative dosing schedules, and 34 were enrolled into expansion cohorts. Doses tested in the expansion cohort were trametinib 1.5 mg once daily (QD) + uprosertib 50 mg QD. Adverse events (AEs) were consistent with those reported in monotherapy studies but occurred at lower doses and with greater severity. Diarrhea was the most common dose-limiting toxicity; diarrhea and rash were particularly difficult to tolerate. Overall, 59% and 6% of patients reported AEs with a maximum severity of grade 3 and 4, respectively. Poor tolerability prevented adequate delivery of uprosertib with trametinib at a concentration predicted to have clinical activity. The study was terminated early based on futility in the continuous-dosing expansion cohorts and a lack of pharmacological or therapeutic advantage with intermittent dosing. The objective response rate was < 5% (1 complete response, 5 partial responses). Continuous and intermittent dosing of trametinib in combination with uprosertib was not tolerated, and minimal clinical activity was observed in all schedules tested. 相似文献
6.
7.
Antoinette Burger Maritha J. Kotze Dan J. Stein Susan Janse van Rensburg Fleur M. Howells 《The European journal of neuroscience》2020,51(4):984-990
Fundamental human studies which address associations between glutamate and iron metabolism are needed. Basic research reports associations between glutamate and iron metabolism. Human studies report sex differences in iron metabolism and glutamate concentrations, which suggest that these relationships may differ by sex. We hypothesised associations would be apparent between in vivo glutamate and peripheral markers of iron metabolism, and these associations would differ by sex. To test this, we recruited 40 healthy adults (20 men, 20 women) and measured (a) standard clinical biomarker concentrations for iron metabolism and (b) an in vivo proxy for glutamate concentration, glutamate with glutamine in relation to total creatine containing metabolites using proton magnetic resonance spectroscopy studies with a two‐dimensional chemical shift imaging slice, with voxels located in bilateral dorsolateral prefrontal cortices, anterior cingulate cortices and frontal white matter. Only the female group reported significant associations between peripheral markers of iron metabolism and Glx:tCr concentration: (a) right dorsolateral prefrontal cortex Glx:tCr associated positively with serum transferrin (r = .60, p = .006) and negatively with transferrin saturation (r = ?.62, p = .004) and (b) right frontal white matter Glx:tCr associated negatively with iron concentration (r = ?.59, p = .008) and transferrin saturation (r = ?.65, p = .002). Our results support associations between iron metabolism and our proxy for in vivo glutamate concentration (Glx:tCr). These associations were limited to women, suggesting a stronger regulatory control between iron and glutamate metabolism. These associations support additional fundamental research into the molecular mechanisms of this regulatory control. 相似文献
8.
Inge A. Mulder MSc Mei Li PhD Tessa de Vries MSc Tao Qin Takeshi Yanagisawa MD PhD Kazutaka Sugimoto MD PhD Antoon van den Bogaerdt PhD A. H. Jan Danser MD PhD Marieke J. H. Wermer MD PhD Arn M. J. M. van den Maagdenberg PhD Antoinette MaassenVanDenBrink PhD Michel D. Ferrari MD PhD Cenk Ayata MD PhD 《Annals of neurology》2020,88(4):771-784
9.
10.
Pagaling Gerald T. Espiritu Adrian I. Dellosa Marie Antoinette A. Leochico Carl Froilan D. Pasco Paul Matthew D. 《Neurological sciences》2022,43(2):811-819
Neurological Sciences - The practice of teleneurology provided an accessible and safe method of consultation during the COVID-19 pandemic. We aimed to describe the practice of teleneurology among... 相似文献